London & Capital Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Sell
15,282
-910,002
-98% -$59.8M 0.01% 119
2026
Q1
$65.8M Sell
925,284
-276,911
-23% -$21.8M 0.72% 30
2025
Q4
$98.6M Buy
1,202,195
+1,163,924
+3,041% +$90.7M 1.02% 26
2025
Q3
$2.87M Buy
38,271
+19,337
+102% +$1.44M 0.21% 50
2025
Q2
$1.4M Buy
+18,934
New +$1.32M 0.11% 68

Other funds holding GEHC

London & Capital Asset Management's GEHC Position: Q2 2026 in Review

London & Capital Asset Management reduced its GE HealthCare (GEHC) stake by 98% in Q2 2026, selling an estimated $59.8M and leaving 15,282 shares worth $978K. The position accounts for 0.01% of the portfolio, ranked #119.

London & Capital Asset Management first reported a position in GEHC in Q2 2025 and has held it in 5 quarters since. The position peaked at $98.6M in Q4 2025. 1,227 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • London & Capital Asset Management held 15,282 shares of GE HealthCare worth $978K as of Q2 2026.
  • London & Capital Asset Management sold 910,002 GE HealthCare shares in Q2 2026, an estimated $59.8M.
  • GE HealthCare made up 0.01% of London & Capital Asset Management's portfolio in Q2 2026, its #119 holding.
  • London & Capital Asset Management first reported a position in GE HealthCare in Q2 2025 and has held it in 5 quarters since.
  • London & Capital Asset Management's GE HealthCare position peaked at $98.6M in Q4 2025.
  • 1,227 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on London & Capital Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.